Literature DB >> 19224918

Interleukin-1 receptor-associated kinase 2 is critical for lipopolysaccharide-mediated post-transcriptional control.

Youzhong Wan1, Hui Xiao, Jeremy Affolter, Tae Whan Kim, Katarzyna Bulek, Sujan Chaudhuri, Deborah Carlson, Thomas Hamilton, Barsanjit Mazumder, George R Stark, James Thomas, Xiaoxia Li.   

Abstract

IRAK2, a member of the interleukin-1 receptor-associated kinase (IRAK) family, has been implicated in Toll-like receptor (TLR)-mediated signaling. We generated IRAK2-deficient mice to examine its function in detail. These mice are resistant to lipopolysaccharide-induced septic shock, because of impaired TLR4-mediated induction of pro-inflammatory cytokines and chemokines. Although IRAK2 deficiency did not affect TLR4-mediated NFkappaB activation, a reduction of lipopolysaccharide (LPS)-mediated mRNA stabilization contributed to the reduced cytokine and chemokine production observed in bone marrow-derived macrophages from IRAK2-deficient mice. Furthermore, the ratios of LPS-induced cytokine and chemokine mRNAs in translation-active (polysomal) versus translation-inactive (free ribosomes) pools were reduced in IRAK2-deficient macrophages compared with wild type macrophages. Importantly, LPS-induced phosphorylation of MKK3/6, MNK1, and eIF4E was significantly reduced in IRAK2-deficient macrophages compared with wild type macrophages. Moreover, LPS stimulation induced an interaction of IRAK2 with TRAF6, MKK3/6, and MK2, implicating a critical role for mitogen-activated protein kinase signaling in LPS-induced IRAK2-mediated post-transcriptional control. These results reveal that IRAK2 is required for LPS-mediated post-transcriptional control of cytokine and chemokine expression, which plays an essential role in TLR4-induced septic shock.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19224918      PMCID: PMC2667724          DOI: 10.1074/jbc.M807822200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  A Toll-like receptor recognizes bacterial DNA.

Authors:  H Hemmi; O Takeuchi; T Kawai; T Kaisho; S Sato; H Sanjo; M Matsumoto; K Hoshino; H Wagner; K Takeda; S Akira
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

2.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components.

Authors:  O Takeuchi; K Hoshino; T Kawai; H Sanjo; H Takada; T Ogawa; K Takeda; S Akira
Journal:  Immunity       Date:  1999-10       Impact factor: 31.745

3.  The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens.

Authors:  D M Underhill; A Ozinsky; A M Hajjar; A Stevens; C B Wilson; M Bassetti; A Aderem
Journal:  Nature       Date:  1999-10-21       Impact factor: 49.962

4.  Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain.

Authors:  L Deng; C Wang; E Spencer; L Yang; A Braun; J You; C Slaughter; C Pickart; Z J Chen
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 5.  Toll-like receptors: critical proteins linking innate and acquired immunity.

Authors:  S Akira; K Takeda; T Kaisho
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

6.  Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9.

Authors:  T H Chuang; R J Ulevitch
Journal:  Eur Cytokine Netw       Date:  2000-09       Impact factor: 2.737

7.  The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5.

Authors:  F Hayashi; K D Smith; A Ozinsky; T R Hawn; E C Yi; D R Goodlett; J K Eng; S Akira; D M Underhill; A Aderem
Journal:  Nature       Date:  2001-04-26       Impact factor: 49.962

8.  Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway.

Authors:  O Takeuchi; A Kaufmann; K Grote; T Kawai; K Hoshino; M Morr; P F Mühlradt; S Akira
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

9.  Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages.

Authors:  D M Underhill; A Ozinsky; K D Smith; A Aderem
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

10.  IL-1 receptor-associated kinase modulates host responsiveness to endotoxin.

Authors:  J L Swantek; M F Tsen; M H Cobb; J A Thomas
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

View more
  45 in total

1.  The dual functions of IL-1 receptor-associated kinase 2 in TLR9-mediated IFN and proinflammatory cytokine production.

Authors:  Youzhong Wan; Tae Whan Kim; Minjia Yu; Hao Zhou; Michifumi Yamashita; Zizhen Kang; Weiguo Yin; Jian-An Wang; James Thomas; Ganes C Sen; George R Stark; Xiaoxia Li
Journal:  J Immunol       Date:  2011-01-26       Impact factor: 5.422

2.  Unique contribution of IRF-5-Ikaros axis to the B-cell IgG2a response.

Authors:  C-M Fang; S Roy; E Nielsen; M Paul; R Maul; A Paun; F Koentgen; F M Raval; E Szomolanyi-Tsuda; P M Pitha
Journal:  Genes Immun       Date:  2012-04-26       Impact factor: 2.676

3.  Activation of cAMP-responsive-element-binding protein by PI3 kinase and p38 MAPK is essential for elevated expression of transforming growth factor β2 in cancer cells.

Authors:  Youzhong Wan; Maojing Yang; Sunny Kolattukudy; George R Stark; Tao Lu
Journal:  J Interferon Cytokine Res       Date:  2010-09       Impact factor: 2.607

4.  IRAK-M mediates Toll-like receptor/IL-1R-induced NFκB activation and cytokine production.

Authors:  Hao Zhou; Minjia Yu; Koichi Fukuda; Jinteak Im; Peng Yao; Wei Cui; Katarzyna Bulek; Jarod Zepp; Youzhong Wan; Tae Whan Kim; Weiguo Yin; Victoria Ma; James Thomas; Jun Gu; Jian-an Wang; Paul E DiCorleto; Paul L Fox; Jun Qin; Xiaoxia Li
Journal:  EMBO J       Date:  2013-02-01       Impact factor: 11.598

5.  Inherited human IRAK-1 deficiency selectively impairs TLR signaling in fibroblasts.

Authors:  Erika Della Mina; Alessandro Borghesi; Hao Zhou; Salim Bougarn; Sabri Boughorbel; Laura Israel; Ilaria Meloni; Maya Chrabieh; Yun Ling; Yuval Itan; Alessandra Renieri; Iolanda Mazzucchelli; Sabrina Basso; Piero Pavone; Raffaele Falsaperla; Roberto Ciccone; Rosa Maria Cerbo; Mauro Stronati; Capucine Picard; Orsetta Zuffardi; Laurent Abel; Damien Chaussabel; Nico Marr; Xiaoxia Li; Jean-Laurent Casanova; Anne Puel
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-09       Impact factor: 11.205

Review 6.  Post-transcriptional regulation of gene expression in innate immunity.

Authors:  Susan Carpenter; Emiliano P Ricci; Blandine C Mercier; Melissa J Moore; Katherine A Fitzgerald
Journal:  Nat Rev Immunol       Date:  2014-06       Impact factor: 53.106

7.  The IκB kinase complex regulates the stability of cytokine-encoding mRNA induced by TLR-IL-1R by controlling degradation of regnase-1.

Authors:  Hidenori Iwasaki; Osamu Takeuchi; Shunsuke Teraguchi; Kazufumi Matsushita; Takuya Uehata; Kanako Kuniyoshi; Takashi Satoh; Tatsuya Saitoh; Mutsuyoshi Matsushita; Daron M Standley; Shizuo Akira
Journal:  Nat Immunol       Date:  2011-10-30       Impact factor: 25.606

8.  IRAKM-Mincle axis links cell death to inflammation: Pathophysiological implications for chronic alcoholic liver disease.

Authors:  Hao Zhou; Minjia Yu; Junjie Zhao; Bradley N Martin; Sanjoy Roychowdhury; Megan R McMullen; Emily Wang; Paul L Fox; Sho Yamasaki; Laura E Nagy; Xiaoxia Li
Journal:  Hepatology       Date:  2016-10-25       Impact factor: 17.425

9.  Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling.

Authors:  Su-Chang Lin; Yu-Chih Lo; Hao Wu
Journal:  Nature       Date:  2010-05-19       Impact factor: 49.962

10.  A mutation in Irak2c identifies IRAK-2 as a central component of the TLR regulatory network of wild-derived mice.

Authors:  James R Conner; Irina I Smirnova; Alexander Poltorak
Journal:  J Exp Med       Date:  2009-06-29       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.